Major changes are on the way in 2022 to ensure all athletes play true!
The UK Anti-Doping Agency (UKAD) followed on communication released by the World Anti-Doping Agency (WADA) with the 2022 Prohibited List. This will come into effect on Saturday 1st January.
In a publication by the UKAD on the 2022 Prohibited List, the major changes included:
“S0. Non-approved Substances
Body Protecting Compound-157 (BPC-157) has now been listed as a prohibited substance. Athletes should remain vigilant for any supplements that market BPC-157 as it is not approved for human consumption.
S3. Beta-2 Agonists
The daily dosing time intervals of inhaled salbutamol have been modified. Permitted doses of salbutamol will now be 600 micrograms over any 8-hour period.
The total permitted daily dose (1,600 micrograms over 24-hours) remains unchanged. If an athlete exceeds the permitted doses, a TUE will be required.
Local injections have been added as prohibited routes of administration in-competition.
- oral, rectal, intramuscular and intravenous routes remain prohibited
- inhaled, intranasal, and dermal routes remain permitted
For more information on how to comply with the new glucocorticoid regulations, please refer to our Glucocorticoid TUE Policy and Frequently Asked Questions document. These can be found in the Special Topics section of the UKAD Medicine Hub”.